-
Supreme Court ACA Reimbursement Case Will Have Minimal Effect On Big Insurers
Wednesday, June 26, 2019 - 4:27pm | 946Read More...A Supreme Court case tackling whether the federal government must reimburse health insurers that lost money participating in the Affordable Care Act is worth billions collectively and will be closely watched — but the outcome is unlikely to have a big impact on the insurers’ bottom...
-
Leerink Upgrades Mednax On Margin Expansion, Share Gains And Valuation
Monday, September 24, 2018 - 3:15pm | 316Read More...Mednax Inc (NYSE: MD) shares came under pressure Friday, dipping about 4 percent after Paul Singer's Elliott Associates declared a reduction in stake held in the company. The Analyst Leerink analyst Ana Gupte upgraded shares of Mednax from Market Perform to Outperform, citing margin turnaround...
-
Leerink's Takeaways From CNBC's 'Healthy Returns' Conference
Saturday, March 31, 2018 - 8:59am | 365Read More...The CNBC Healthy Returns Conference recently came to an end, and Leerink analyst Ana Gupte summarized the key takeaways from the event in a note on Thursday. Here’s what investors need to know: According to venture capital and private equity investors, one of the largest investment...
-
Cigna To Buy Express Scripts In $67 Billion Deal: What You Need To Know
Thursday, March 8, 2018 - 9:32am | 463Read More...Health insurer giant CIGNA Corporation (NYSE: CI) reached an agreement to buy Express Scripts Holding Company (NASDAQ: ESRX) in a deal which values the pharmacy benefits manager's stock at $96.03 per share, or $67 billion for the entire company. What Happened Cigna reached an agreement to...
-
After A Q4 Miss, LifePoint Health Downgraded By Leerink On Free Cash Flow Concerns
Monday, March 5, 2018 - 10:40am | 389Read More...Health care services provider LifePoint Health Inc (NASDAQ: LPNT) was hit with a downgrade by Leerink Swan while still recovering from a Friday earnings miss and subsequent stock plunge. The Rating Analyst Ana Gupte downgraded LifePoint from Outperform to Market Perform and lowered the price...
-
Express Scripts: Another Potential Amazon Victim?
Tuesday, October 10, 2017 - 3:31pm | 448Read More...Rumors that Amazon.com, Inc. (NASDAQ: AMZN) may soon be jumping into the pharmacy business have weighed on drug retailers Walgreens Boots Alliance Inc (NASDAQ: WBA) and CVS Health Corp (NYSE: CVS). However, pharmacy benefit managers, which serve as middlemen between insurers and pharmaceutical...
-
Analyst: Amazon's Entry Into Pharmacy Is All But Certain At This Point
Friday, October 6, 2017 - 1:37pm | 471Read More...Pharmacy and health care investors should brace themselves — Amazon.com, Inc (NASDAQ: AMZN) is coming. In a pair of new research notes out this week, analysts at Leerink said it’s not a matter of if Amazon will make a move into the prescription drug business, it’s a matter of...
-
Express Scripts' Potential Breakup With Anthem, Explained
Wednesday, April 26, 2017 - 12:00pm | 679Read More...Express Scripts Holding Company (NASDAQ: ESRX) shares are bouncing back by 2.9 percent Wednesday after plummeting 10.7 percent Tuesday on news it is likely losing its largest customer, Anthem Inc (NYSE: ANTM). On Monday after the market close, Express issued a press release suggesting Anthem would...
-
Leerink Downgrades Community Health Systems, Sees Challenges Coming
Tuesday, October 27, 2015 - 10:59am | 224Read More...Community Health Systems (NYSE: CYH) shares have been declining steadily in 2015 and are down 49 percent year-to-date. Leerink’s Ana Gupte downgraded the rating on the company from Outperform to Market Perform, while reducing the price target from $75 to $33. Weaker volumes, payor...
-
Managed Care Stocks Might Be The Best Defense Against Market Volatility
Wednesday, August 26, 2015 - 12:06pm | 366Read More...In a new report, Leerink analyst Ana Gupte offered one possible source of value following the recent market selloff: managed care stocks. Gupte sees further upside from many names in the space following big Q2 earnings beats. ‘Beats And Raises’ All year, managed care stocks have...
-
How The $54.2 Billion Anthem-Cigna Deal Benefits Both Companies
Friday, July 24, 2015 - 12:18pm | 339Read More...Anthem Inc (NYSE: ANTM) announced on Friday that it will be buying competitor CIGNA Corporation (NYSE: CI) in a $54.2 billion cash and stock deal. Ana Gupte, Leerink Partners senior health care analyst, was on CNBC to discuss the deal and how it benefits both companies and their shareholders....
-
How The Street Is Reacting To The Aetna-Humana Deal
Monday, July 6, 2015 - 2:31pm | 713Read More...Aetna Inc (NYSE: AET) reached a deal early Friday morning to buy out rival health insurer Humana Inc (NYSE: HUM) for a combination of cash and stock. The $37 billion agreement valued Humana at $230 per share, 23 percent higher than its closing price on Thursday. Analysts on the Street have mixed...
-
ACA Will Stay: What Wall Street Is Saying About Tenet Healthcare
Monday, June 29, 2015 - 11:37am | 557Read More...It looks like the Affordable Care Act, or ACA, is here to stay after last week’s Supreme Court ruling. Since the fate of the ACA has been questionable since it was signed into law in 2011, analysts now feel comfortable recommending stocks in the healthcare sector such as Tenet Healthcare...
-
Leerink Sees Humana Takeout At $220/Share Or More
Friday, June 26, 2015 - 1:19pm | 312Read More...Humana Inc (NYSE: HUM) will sell itself to Aetna Inc (NYSE: AET) for $220 or more, an analyst said Friday. Leerink's Ana Gupte offered a broad view of the apparently pending wave of insurance sector mergers following reports that Humana and Aetna are close to a deal. CIGNA Corporation (...
-
Anthem-Cigna Deal Will Still Happen, Leerink Says
Tuesday, June 23, 2015 - 4:23pm | 302Read More...CIGNA Corporation (NYSE: CI) is likely to accept a bid of $190 a share from Anthem Inc (NYSE: ANTM) an analyst said Tuesday. Cigna, which rejected a $184 a share cash-and-stock bid from Anthem on Sunday, traded recently at $164.75, up $1.35. Leerink's Ana Gupta said the deal between the...
